WDR-5 protein inhibitors (Ascentage Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameWDR-5 protein inhibitors (Ascentage Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWD repeat-containing protein 5 degraders
TargetsWD repeat-containing protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAscentage Pharma Group International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAscentage Pharma Group International
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A